Stoke Therapeutics Inc (STOK) — Cash Flow Quality Index

Latest as of March 2025: 1.17x

Stoke Therapeutics Inc (STOK) has a Cash Flow Quality Index of 1.17x as of March 2025. Operating cash flow of $131.83 Million exceeds net income of $112.88 Million, indicating high earnings quality where cash backs reported profits. Explore STOK long-term investments to assets to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

1.17x

Operating CF / Net Income

Operating Cash Flow

$131.83 Million

USD

Net Income

$112.88 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Stoke Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Stoke Therapeutics Inc. For live market cap and the full company financial profile, see STOK stock market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.